Matthew Rowe

Matthew Rowe is an experienced National Account Manager and Oncology Diagnostic Specialist with a demonstrated history of success in the healthcare and diagnostics industry. Currently employed at Merck and Amplity Health since April 2016, Matthew has received multiple Annual ODS Leader Awards (2017, 2018) for outstanding performance, particularly in the consultative role for the immunotherapy treatment Keytruda. Previous roles include Executive Sales Representative at CBLPath, Mid-Atlantic Sales Manager at Signal Genetics, and Account Executive positions at Clarient/GE Healthcare and Myriad Genetics, where Matthew consistently exceeded sales quotas and contributed to the launch of innovative diagnostic tests. Matthew holds a Bachelor of Arts in Political Science and Government/Russian from West Chester University of Pennsylvania and has an extensive background in sales within the healthcare sector, showcasing strong organizational and strategic skills throughout a nearly three-decade career.